// App-Quantinova.ai

: Association of combined anxiety and depression with quality of life, dyspnea, exercise tolerance in COPD patients

Researchers

Presenter

  • Abebaw Mengistu Yohannes

Principal Investigators

  • Richard Casaburi

  • Sheila Dryden

  • Nicola Alexander Hanania

Medical Centers

  • St. Annes Primary Care Center, Lytham, Lancashire, Lytham, United Kingdom

  • Department of Physical Therapy, Azusa Pacific University, Azusa, United States of America

  • Section of Pulmonary and Critical Care Medicine, Bayor College of Medicine, Houston, TX, United States,

  • Rehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrence, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Genetic Disorder

Disease

  • Depression

  • Anxiety

  • Dyspnea

  • Chronic obstructive pulmonary disease

  • Dental anomalies and short stature

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A